GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act Statement 2024 (PDF - 162.5KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study reg...
GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 GSK plc at a glance Our purpose We unite science, technology and talent to get ahead of disease together For health impact + shareholder returns + thriving people About our new logo The new logo reflects our new purpose and growth ...
GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG> Modern Slavery Act Statement 2024 (PDF - 162.5KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study ...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DGGSK websites GSK Global website Locations selector Global Behind the science GSKPro for HCPs ViiV Healthcare GSK study register Business to Business Quick...
© 2001-2023 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Modern Slavery Act statement 2022...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation forJemperli(dostarlimab-gxly) for the treatment of patients with locally advanced mismatch repair deficient (dMMR)...
PLYMOUTH, Mass.--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment...
GlaxoSmithKline plc(NYSE: GSK) Q2 2021 Earnings Call Jul 28, 2021,9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, ladies and gentlemen, and welcome to the Analyst Call on the GSK Second Quarter 2021 results. I will no...